The issues with tissues: the wide range of cell fate separation enables the evolution of multicellularity and cancer

  • Emma U. Hammarlund*
  • , Sarah R. Amend
  • , Kenneth J. Pienta
  • *Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

52 Downloads (Pure)

Abstract

Our understanding of the rises of animal and cancer multicellularity face the same conceptual hurdles: what makes the clade originate and what makes it diversify. Between the events of origination and diversification lies complex tissue organization that gave rise to novel functionality for organisms and, unfortunately, for malignant transformation in cells. Tissue specialization with distinctly separated cell fates allowed novel functionality at organism level, such as for vertebrate animals, but also involved trade-offs at the cellular level that are potentially disruptive. These trade-offs are under-appreciated and here we discuss how the wide separation of cell phenotypes may contribute to cancer evolution by (a) how factors can reverse differentiated cells into a window of phenotypic plasticity, (b) the reversal to phenotypic plasticity coupled with asexual reproduction occurs in a way that the host cannot adapt, and (c) the power of the transformation factor correlates to the power needed to reverse tissue specialization. The role of reversed cell fate separation for cancer evolution is strengthened by how some tissues and organisms maintain high cell proliferation and plasticity without developing tumours at a corresponding rate. This demonstrates a potential proliferation paradox that requires further explanation. These insights from the cancer field, which observes tissue evolution in real time and closer than any other field, allow inferences to be made on evolutionary events in animal history. If a sweet spot of phenotypic and reproductive versatility is key to transformation, factors stimulating cell fate separation may have promoted also animal diversification on Earth.

OriginalsprogEngelsk
Artikelnummer62
TidsskriftMedical Oncology
Vol/bind37
Udgave nummer7
Antal sider12
ISSN1357-0560
DOI
StatusUdgivet - 2020

Finansiering

This work was funded by Swedish Research Council Grant 2019-05254 to EUH; European Union's Horizon 2020 research and innovation programme (Marie Sklodowska-Curie Grant Agreement No. 690817); the Patrick C. Walsh Prostate Cancer Research Fund and the Prostate Cancer Foundation to SRA; and NCI Grants U54CA143803, CA163124, CA093900, and CA143055, and the Prostate Cancer Foundation to KJP. KJP is a consultant and hold stocks for Cue Biopharma, Inc., Greenmark Biomedical, Inc., MEDSYN Biopharma, LLC, and Oncopia Therapeutics. LLC. KJP is a consultant for Akrevia Therapeutics, Inc., GloriousMed, Inc, Arkray, Inc., and Clinomics, Inc. KJP receives research funding from Progenics, Inc.

Fingeraftryk

Dyk ned i forskningsemnerne om 'The issues with tissues: the wide range of cell fate separation enables the evolution of multicellularity and cancer'. Sammen danner de et unikt fingeraftryk.

Citationsformater